Detalles de la búsqueda
1.
Treatment of post-allogeneic hematopoietic stem cell transplant cytopenias with sequential doses of multipotent mesenchymal stromal/stem cells.
Cytotherapy
; 2024 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38727653
2.
Peripheral blood stem cell versus bone marrow graft for patients ≥60 years undergoing reduced intensity conditioning haploidentical transplantation for acute myeloid leukemia in complete remission: An analysis of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Am J Hematol
; 99(7): 1250-1256, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38778766
3.
Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study.
Lancet Oncol
; 24(8): 913-924, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37414060
4.
The CAR-HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL.
Am J Hematol
; 98(11): 1699-1710, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37584447
5.
Primary Cutaneous Marginal Zone Lymphoproliferative Disorder of Donor Origin after Allogeneic Hematopoietic Stem Cell Transplantation.
Am J Dermatopathol
; 45(6): 378-382, 2023 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37130208
6.
Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients.
Ann Hematol
; 101(9): 2053-2067, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35780254
7.
SARS-CoV-2-reactive antibody detection after SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group.
Am J Hematol
; 97(1): 30-42, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34695229
8.
Defibrotide in hematopoietic stem cell transplantation: A multicenter survey study of the Spanish Hematopoietic Stem Cell Transplantation Group (GETH).
Eur J Haematol
; 106(6): 842-850, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33713387
9.
Treatment of steroid-refractory chronic graft-versus-host disease with imatinib: Real-life experience of the Spanish group of hematopoietic transplantation (GETH).
Clin Transplant
; 35(5): e14255, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33595866
10.
Biomarker profile predicts clinical efficacy of extracorporeal photopheresis in steroid-resistant acute and chronic graft-vs-host disease after allogenic hematopoietic stem cell transplant.
J Clin Apher
; 36(5): 697-710, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34185332
11.
Response to Novel Drugs before and after Allogeneic Stem Cell Transplantation in Patients with Relapsed Multiple Myeloma.
Biol Blood Marrow Transplant
; 25(9): 1703-1712, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31054983
12.
Optimized EBMT transplant-specific risk score in myelodysplastic syndromes after allogeneic stem-cell transplantation.
Haematologica
; 104(5): 929-936, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30655377
13.
CD34+ Cell Selection versus Reduced-Intensity Conditioning and Unmodified Grafts for Allogeneic Hematopoietic Cell Transplantation in Patients Age >50 Years with Acute Myelogenous Leukemia and Myelodysplastic Syndrome .
Biol Blood Marrow Transplant
; 24(5): 964-972, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29305194
14.
Immune status of high-risk smoldering multiple myeloma patients and its therapeutic modulation under LenDex: a longitudinal analysis.
Blood
; 127(9): 1151-62, 2016 Mar 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-26668134
15.
Busulfan-based myeloablative conditioning regimens for haploidentical transplantation in high-risk acute leukemias and myelodysplastic syndromes.
Eur J Haematol
; 101(3): 332-339, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29846964
16.
Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma.
N Engl J Med
; 369(5): 438-47, 2013 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23902483
17.
Incidence and risk factors for life-threatening bleeding after allogeneic stem cell transplant.
Br J Haematol
; 169(5): 719-25, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25817436
18.
The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Haematologica
; 100(5): 683-9, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25769546
19.
Sequential third-party mesenchymal stromal cell therapy for refractory acute graft-versus-host disease.
Biol Blood Marrow Transplant
; 20(10): 1580-5, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24952358
20.
Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies.
Haematologica
; 99(8): 1365-72, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24816239